A federal judge has approved a $70 million settlement reached by a class of drug purchasers with Merck & Co Inc and Glenmark Pharmaceuticals over claims that the two drugmakers colluded to delay ...

Glenmark Pharmaceuticals recalled 114 batches of potassium chloride extended-release capsules, and American Health Packaging recalled 21 batches of the same capsules last week.

Shares of Mumbai-based Glenmark Pharmaceuticals fell 4.5% to Rs 790.25 on the National Stock Exchange (NSE) in early trade on Friday, following the company's announcement of a significant ...

FDA inspectors found serious problems at a Glenmark factory in India that manufactured the recalled drugs. Another medication made there has been tied to deaths of U.S. patients.

Glenmark Pharmaceuticals has entered (PDF) the subcutaneous checkpoint inhibitor space, agreeing to pay "low double-digit millions" for the chance to launch envafolimab in markets including India ...

Generic drugmakers Teva Pharmaceutical Industries Ltd and Glenmark Pharmaceuticals USA cannot see evidence presented by federal prosecutors to a grand jury in a criminal case accusing them of ...

Glenmark is expanding its OTC portfolio. The company has acquired Wockhardt’s approved ANDAs for famotidine tablets, 10 mg and 20 mg (OTC); cetirizine hydrochloride tablets, 5 mg and 10 mg (OTC ...

While Glenmark returned to profitability, reporting a net profit of ₹4.7 crore versus a loss of ₹1,218 crore in the same quarter last year, the EBITDA margin improvement to 17.2% (from 16.5% ...

Investing.com -- Glenmark Pharmaceuticals (NSE:GLEN) Inc., USA has launched the Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL), a product that is bioequivalent and therapeutically equivalent ...

Mahwah, N.J.-based Glenmark recently agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a ...

By divesting 75% of its API business, Glenmark has resolved its debt problem. The buyer is Nirma, which will pay 615 Indian rupees per share ($681 million).

Drugmaker Glenmark Pharmaceuticals Limited has said that a wholly-owned subsidiary Glenmark Consumer Care Limited has been incorporated, to manufacture and market its pharmaceutical and consumer ...